We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Acneiform eruption during therapy with aflibercept for metastatic colorectal carcinoma.
- Authors
Martínez‐Doménech, Alvaro; García‐Legaz Martínez, Marta; Magdaleno‐Tapial, Jorge; Valenzuela‐Oñate, Cristian; Pérez‐Pastor, Gemma; Alegre‐de Miquel, Víctor; Pérez‐Ferriols, Amparo
- Abstract
Aflibercept is an antiangiogenic fully human monoclonal antibody against vascular endothelial growth factor (VEGF) A and B and placental growth factor, another VEGF subfamily member. Treatment with FOLFIRI/aflibercept was resumed, and topical therapy maintained adequate control of lesions. Dermatological evaluation is essential for the optimal management of patients developing adverse reactions to oncologic therapies.
- Subjects
ACNEIFORM eruptions; VASCULAR endothelial growth factors; ENDOTHELIAL growth factors; PLACENTAL growth factor; DRUG side effects
- Publication
Australasian Journal of Dermatology, 2020, Vol 61, Issue 1, pe107
- ISSN
0004-8380
- Publication type
Article
- DOI
10.1111/ajd.13120